Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Bristol-Myers Squibb Co. (BMY) PT Raised to $53 at TD Cowen
-
TD Cowen Reiterates Hold Rating on Bristol-Myers Squibb Co. (BMY)
-
Bristol Myers Squibb to Participate in the TD Cowen 44th Annual Health Care Conference
-
Bristol-Myers Squibb Co. (BMY) PT Lowered to $67 at TD Cowen
-
Bristol Myers Squibb to Participate in Cowen’s 43rd Annual Health Care Conference
-
Pre-Open Stock Movers: Bristol-Myers Jumps on FDA Approval, Carvana Gains on Upgrade
-
Bristol-Myers Squibb Co. (BMY) Sotyktu Label Better-than-Expected - Cowen
-
Bristol Myers Squibb (BMY) Sliding on milvexian Readout, Analysts See Data as “Risky”
-
U.S. FDA approves Bristol Myers' bowel disease treatment
-
Bristol Myers Squibb to Take Part in the Cowen Virtual 41st Annual Health Care Conference
-
Bristol-Myers Squibb Co. (BMY) PT Lowered to $66 at Cowen
-
Cullinan Oncology Completes $98.5 Million Series B Financing
-
Bristol-Myers Squibb Co. (BMY) Estimate Raised At Cowen
-
Bristol-Myers Squibb to Take Part in the Cowen and Company 39th Annual Health Care Conference
-
Bristol-Myers Squibb Co. (BMY) PT Lowered to $60 at Cowen
-
Bristol-Myers Squibb to Take Part in Cowen and Company 38th Annual Global Health Care Conference
-
Bristol-Myers Squibb to Take Part in Cowen and Company 37th Annual Global Health Care Conference
-
Bristol-Myers lung cancer delay slams shares, keeps Merck in lead
-
Cowen Downgrades Bristol-Myers Squibb Co. (BMY) to Market Perform
-
Trading Radar for 10/27: Alphabet (GOOG), Amazon (AMZN), Twitter (TWTR) Ford (F), Baidu.com (BIDU) Report
-
Notable Analyst Rating Changes 8/11: (COG) (TMH) (AEO) Upgraded; (QHC) (CBOE) (BMY) Downgraded
-
Trading Radar for 7/28: Alphabet (GOOG), Amazon (AMZN), Ford (F), Baidu (BIDU), MasterCard (MA) Report
-
Trading Radar for 4/28: Ford (F), Amazon (AMZN), Viacom (VIAB), LinkedIn (LNKD), Pandora (P), Aetna (AET) Report
-
Bristol-Myers Squibb to Present at Cowen and Company Annual Global Health Care Conference
-
Cowen Raises Price Target as IO Drives Bristol-Myers Squibb (BMY)
-
Ovid Therapeutics Announces Appointment of Dr. Anna Kazanchyan to Senior Vice President, Business Development
-
Notable Analyst Rating Changes 05/15: (PLUG) (PTX) (TWTR) Upgraded; (BMY) (HII) (CXP) Downgraded
-
Notable Analyst Rating Changes 09/16: (HUN) (BMY) (BX) Upgraded; (NVS) (PXD) (DSX) Downgraded
-
Stocks Crossing 50-Day SMA 12/31: (HPQ) (ZNGA) (MCP) Above; (PFE) (VVUS) (WPI) Below
-
Notable Analyst Rating Changes 09/11: (BMY) (SYNC) (JAZZ) Upgraded; (SIRI) (TIBX) (GNOM) Downgraded
-
VIVUS (VVUS) Could Be Bought For Up to $40/Share
-
George Soros' Hedge Fund Slashes Stake In Gold ETF (GLD), Raises Stake in Citi (C) and AT&T (T)
-
Daily State of the Markets 02/07: Irrelevant?
-
Cowen Upgrades Bristol-Myers (BMY) to Outperform, Downgrades Merck (MRK) to Neutral
-
Notable Analyst Rating Changes 03/05: DISH, TIVO, CWTR, CIEN, BMY Upgraded; WEN, TSN, AUY, WBD Downgraded
-
Notable Analyst Rating Changes: MS, BA, UNH, INTC, UPL, FTO, More Upgraded; BMY, CHK, BSX, MELI, More Downgraded
-
Notable Analyst Rating Changes 10/9: VIA, AKS, SY, MAR, RIMM; ARO, MT, BMY, LTD Downgrade
-
Cowen & Co Downgrades Bristol-Myers (BMY) to Neutral
-
Notable Analyst Rating Changes 8/28: JCG, WSM, NOK, ARUN Upgraded; POT, MOS, BA, ENER, BMY Downgraded
-
Notable Analyst Rating Changes 12/10: RTP, BMY, HE Upgraded; GE, NUE, EBAY, ERTS Downgraded
-
Notable Analyst Rating Changes 11/07: ANF, TWTC, CECEO Upgraded; TM, DLB, SI Downgraded
-
Notable Analyst Rating Changes 10/08: BMY, NUE, SYMC Upgraded; TM, X, UPS, F, GM Downgraded
-
Pre-Open Movers 9/23: ImClone (IMCL) Up on Raised Bid; Cache (CACH) Sinks On Lower Guidance

